Seroatlas · Human Serome Atlas

CGB7

Choriogonadotropin subunit beta 7

Also known as: CG-beta-a, CGB7_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: P0DN87
Gene: CGB7
Ensembl: ENSG00000196337
Chromosome: 19
Canonical length: 165 aa
Protein class: Predicted secreted proteins
Secretome location: Secreted in other tissues

OverviewNCBI Gene

This gene is a member of the glycoprotein hormone beta chain family and encodes the beta 7 subunit of chorionic gonadotropin (CG). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. The beta subunit of CG is encoded by 6 genes which are arranged in tandem and inverted pairs on chromosome 19q13.3 and contiguous with the luteinizing hormone beta subunit gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

165 residues, UniProt reviewed canonical sequence.

>P0DN87|CGB7
     1  MEMFQGLLLL LLLSMGGTWA SREMLRPRCR PINATLAVEK EGCPVCITVN TTICAGYCPT
    61  MTRVLQGVLP ALPQVVCNYR DVRFESIRLP GCPRGVNPVV SYAVALSCQC ALCRRSTTDC
   121  GGPKDHPLTC DDPRFQASSS SKAPPPSLPS PSRLPGPSDT PILPQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CGB7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Secreted
Secreted: Yes
Transmembrane segments: 0
Mean surface accessibility (rSASA): 0.49
Highest tissue expression: 2.8 nTPM

Expression across tissuesHPA

Tissue

pancreas: 2.8 nTPM
skin: 2.7 nTPM
skeletal muscle: 2.4 nTPM
prostate: 2 nTPM
esophagus: 1.6 nTPM
vagina: 1.3 nTPM

Single-cell type

syncytiotrophoblasts: 86 nCPM
extravillous trophoblasts: 10 nCPM
medullary thymic epithelial cells: 4.8 nCPM
epididymal basal cells: 3.1 nCPM
basal prostatic cells: 1.5 nCPM
early primary spermatocytes: 1.5 nCPM

Immune cell

basophil: 0 nTPM
classical monocyte: 0 nTPM
eosinophil: 0 nTPM
gdT-cell: 0 nTPM
intermediate monocyte: 0 nTPM
MAIT T-cell: 0 nTPM

Brain region

midbrain: 1.1 nTPM
cerebral cortex: 0.9 nTPM
choroid plexus: 0.7 nTPM
hippocampal formation: 0.7 nTPM
amygdala: 0.6 nTPM
cerebellum: 0.5 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance): 1.89
gnomAD pLI: 0.01
gnomAD missense Z: -0.92
DepMap mean gene effect: 0.01
DepMap dependency class: selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

hormone activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CGB7 as an antibody target. Whether an autoantibody or antibody against CGB7 could matter depends on whether native CGB7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CGB7 is annotated as secreted, so native CGB7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CGB7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...